- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x XT5: 5-[(4-cyclopropyl-1,2,3-triazol-1-yl)methyl]-2-(2-methylphenoxy)phenol(Non-covalent)
XT5.2: 17 residues within 4Å:- Chain A: G.116, F.117, M.118, M.123, F.169, P.176, A.177, Y.178, M.181, K.185, A.218, M.219, I.222, Q.234, L.237, L.238
- Ligands: NAD.1
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:A.177, A:Y.178, A:Y.178, A:A.218, A:M.219, A:I.222, A:L.237, A:L.238
- Hydrogen bonds: A:Y.178, A:Q.234
XT5.7: 16 residues within 4Å:- Chain B: G.116, F.117, M.118, M.123, F.169, P.176, A.177, Y.178, K.185, A.218, M.219, I.222, V.223, Q.234, L.238
- Ligands: NAD.6
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:A.177, B:Y.178, B:A.218, B:M.219, B:I.222, B:V.223, B:Q.234, B:L.238
- Hydrogen bonds: B:Y.178, B:Q.234
- pi-Stacking: B:F.169
XT5.10: 17 residues within 4Å:- Chain C: G.116, F.117, M.118, M.123, F.169, P.176, A.177, Y.178, M.181, K.185, A.218, M.219, I.222, Q.234, L.237, L.238
- Ligands: NAD.9
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:A.177, C:Y.178, C:Y.178, C:A.218, C:M.219, C:I.222, C:L.237, C:L.238
- Hydrogen bonds: C:Y.178, C:Y.178, C:Q.234
XT5.15: 16 residues within 4Å:- Chain D: G.116, F.117, M.118, M.123, F.169, P.176, A.177, Y.178, K.185, A.218, M.219, I.222, V.223, Q.234, L.238
- Ligands: NAD.14
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:A.177, D:Y.178, D:A.218, D:M.219, D:I.222, D:V.223, D:Q.234, D:L.238
- Hydrogen bonds: D:Y.178, D:Y.178, D:Q.234
- pi-Stacking: D:F.169
- 8 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 3 residues within 4Å:- Chain A: R.215, M.219, S.220
Ligand excluded by PLIPCL.4: 3 residues within 4Å:- Chain A: L.81, E.82, R.97
Ligand excluded by PLIPCL.5: 4 residues within 4Å:- Chain A: P.271
- Chain D: T.256, P.257, K.260
Ligand excluded by PLIPCL.8: 4 residues within 4Å:- Chain B: F.169, D.170, A.210, A.211
Ligand excluded by PLIPCL.11: 3 residues within 4Å:- Chain C: R.215, M.219, S.220
Ligand excluded by PLIPCL.12: 3 residues within 4Å:- Chain C: L.81, E.82, R.97
Ligand excluded by PLIPCL.13: 4 residues within 4Å:- Chain B: T.256, P.257, K.260
- Chain C: P.271
Ligand excluded by PLIPCL.16: 4 residues within 4Å:- Chain D: F.169, D.170, A.210, A.211
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Spagnuolo, L.A. et al., Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors. J. Am. Chem. Soc. (2017)
- Release Date
- 2017-02-15
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
DC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x XT5: 5-[(4-cyclopropyl-1,2,3-triazol-1-yl)methyl]-2-(2-methylphenoxy)phenol(Non-covalent)
- 8 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Spagnuolo, L.A. et al., Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors. J. Am. Chem. Soc. (2017)
- Release Date
- 2017-02-15
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
DC
CD
D